BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22925898)

  • 1. The RanBP2/RanGAP1*SUMO1/Ubc9 complex: a multisubunit E3 ligase at the intersection of sumoylation and the RanGTPase cycle.
    Flotho A; Werner A
    Nucleus; 2012; 3(5):429-32. PubMed ID: 22925898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
    Werner A; Flotho A; Melchior F
    Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
    Gareau JR; Reverter D; Lima CD
    J Biol Chem; 2012 Feb; 287(7):4740-51. PubMed ID: 22194619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
    Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
    Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex.
    Sakin V; Richter SM; Hsiao HH; Urlaub H; Melchior F
    J Biol Chem; 2015 Sep; 290(39):23589-602. PubMed ID: 26251516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
    Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
    J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly.
    Swaminathan S; Kiendl F; Körner R; Lupetti R; Hengst L; Melchior F
    J Cell Biol; 2004 Mar; 164(7):965-71. PubMed ID: 15037602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
    Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
    Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.
    Sommer S; Ritterhoff T; Melchior F; Mootz HD
    Chembiochem; 2015 May; 16(8):1183-9. PubMed ID: 25917782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.
    He Y; Yang Z; Zhao CS; Xiao Z; Gong Y; Li YY; Chen Y; Du Y; Feng D; Altman A; Li Y
    Elife; 2021 Jun; 10():. PubMed ID: 34110283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
    Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
    Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characterization and Functional Analysis of Annulate Lamellae Pore Complexes in Nuclear Transport in Mammalian Cells.
    Raghunayakula S; Subramonian D; Dasso M; Kumar R; Zhang XD
    PLoS One; 2015; 10(12):e0144508. PubMed ID: 26642330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
    Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
    Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumoylation of human argonaute 2 at lysine-402 regulates its stability.
    Sahin U; Lapaquette P; Andrieux A; Faure G; Dejean A
    PLoS One; 2014; 9(7):e102957. PubMed ID: 25036361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
    Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO modification through rapamycin-mediated heterodimerization reveals a dual role for Ubc9 in targeting RanGAP1 to nuclear pore complexes.
    Zhu S; Zhang H; Matunis MJ
    Exp Cell Res; 2006 Apr; 312(7):1042-9. PubMed ID: 16469311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performing in vitro sumoylation reactions using recombinant enzymes.
    Werner A; Moutty MC; Möller U; Melchior F
    Methods Mol Biol; 2009; 497():187-99. PubMed ID: 19107418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.
    Gilistro E; de Turris V; Damizia M; Verrico A; Moroni S; De Santis R; Rosa A; Lavia P
    J Cell Sci; 2017 Aug; 130(15):2564-2578. PubMed ID: 28600321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.